In a small trial, people lost more weight and fat while eating a diet rich in minimally processed foods than they did eating ...

Online telehealth company Hims and Hers Health missed Wall Street estimates for second-quarter revenue on Monday, as it lost subscribers for compounded versions of weight-loss drugs, sending its ...

A MUM has claimed she almost died when the skinny jabs she used to fit into her holiday clothes left her suffering serious ...

MCK's Q1 results are expected to reflect strong prescription volume growth from GLP-1 demand, but lower margins may weigh on profitability.

Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced a new strategic direction with an increasing focus on low-dose GLP-1 combination therapy, ...

Hims & Hers stock dropped a sharp 11% after the company missed Q2 2025 revenue estimates, raising concerns about its booming ...

Most employees said health plans should cover GLP-1 medications, with 64% saying they should and 12% saying they should not.

Clare Reid, 49, was looking forward to a big trip to Dubai with her daughter and wanted to fit into her holiday clothes, so ...

GPs should monitor patients who have taken weight loss medication ‘for a minimum of one year’ after treatment is completed, ...

Lizzo discussed the realities of her weight lost journey, adding: “There were times when I would eat so much that my stomach ...

Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price. The 'microdose' ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some success ...